The Trump administration issued a rule barring Medicaid and CHIP from funding puberty blockers, hormone therapy, and surgeries for minors with gender dysphoria. Reporting on the announcement originates from two right-leaning outlets and attributes supporting statements to an HHS official whose position and remarks remain unverified beyond those sources. Multiple aspects of the policy's implementation, legal status, and related claims lack independent confirmation.